mobile header bg
Tecelra afamitresgene autoleucel logo

NOW APPROVED

When other kinds of treatment do not work

TECELRA is a one-time treatment for certain adults with advanced synovial sarcoma

TECELRA is a medicine, called a genetically modified autologous T-cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you. TECELRA is approved based on patient response data. Additional data are needed to confirm the clinical benefit of TECELRA. It is not known if TECELRA is safe and effective in children.
Have questions about patient support and resources that may be available to you?
Explore support & resources
Visit AdaptimmuneAssist.com
Contact AdaptimmuneAssist by calling 1‑855‑24MYADAP (855‑246‑9232), Monday through Friday 8:00 AM to 8:00 PM ET, or emailing adaptimmuneassist@adaptimmune.com.
Advanced synovial sarcoma and a unique treatment approach

About TECELRA

TECELRA is a TCR T-cell therapy, a different kind of treatment for certain adults with advanced synovial sarcoma when other kinds of treatment do not work
Loading...
Loading...
Loading...
Loading...
Loading...

Support & Resources

Starting the conversation about TECELRA

If you are an adult, have been diagnosed with advanced synovial sarcoma, and previous treatments have not worked:

Chat Icon

STEP 1

Speak to Your Doctor

You can be an advocate for your treatment journey. Ask if your doctor has heard of TECELRA and if it may be an option for you.

Testing Icon

STEP 2

Testing for TECELRA Eligibility

Your doctor will order testing to see if this personalized T-cell therapy is right for you. You will need to take a blood test and a tumor tissue test.
Learn more about these tests.

Person Icon

STEP 3

Starting TECELRA

If the results of your tests confirm TECELRA is an option for you, you and your care team may discuss next steps, including treatment with TECELRA.

AdaptimmuneAssist Logo

AdaptimmuneAssist is your dedicated support team

AdaptimmuneAssist provides access support for patients, their caregivers, and doctors and care teams throughout the TECELRA treatment journey. Your Cell Therapy Navigator (CTN) can help you access resources that may be helpful to you.

Phone Icon

Have questions or want to learn more?

Contact AdaptimmuneAssist by calling 1‑855‑24MYADAP (855‑246‑9232), Monday through Friday 8:00 AM to 8:00 PM ET or emailing adaptimmuneassist@adaptimmune.com.

Learn more on the AdaptimmuneAssist website

Right Arrow

More Support & Resources

Support and advocacy groups

Cancer organizations and patient support groups may offer information about cancer, help you through your treatment journey, or connect you with a local support group. These can be places to share experiences, learn about the latest cancer news, and even get encouragement from a community that understands what you are going through.

Select the logos below to visit these sites and learn more about how they can provide support and community for you and your patients.

Please note: AdaptimmuneAssist is not affiliated with these independent third‑party organizations and is not responsible for their views or services.

SFASarcoma AllianceNorthwest Sarcoma FoundationRein In SarcomaMercy Medical AngelsCANpaf

Find a Treatment Center that administers TECELRA

Start here

INDICATION and IMPORTANT SAFETY INFORMATION

line

IMPORTANT SAFETY INFORMATION

Important Warning: You will likely be in a hospital before and after getting TECELRA. TECELRA may cause side effects that can be severe or life-threatening. Call your healthcare provider or get emergency help right away if you get any of the following: fever (100.4°F/38°C or higher); chills/shivering; difficulty breathing; fast or irregular heartbeat; low blood pressure; fatigue; severe nausea, vomiting, or diarrhea; severe headache; or new skin rash. Tell all your healthcare providers that they were treated with TECELRA.

After getting TECELRA, you will be monitored daily at the healthcare facility for at least 7 days after the infusion. You should plan to stay close to a healthcare facility for at least 4 weeks. Do not drive, operate heavy machinery, or do other activities that could be dangerous for at least 4 weeks after you get TECELRA.

INDICATION and IMPORTANT SAFETY INFORMATION

line

IMPORTANT SAFETY INFORMATION

Important Warning: You will likely be in a hospital before and after getting TECELRA. TECELRA may cause side effects that can be severe or life-threatening. Call your healthcare provider or get emergency help right away if you get any of the following: fever (100.4°F/38°C or higher); chills/shivering; difficulty breathing; fast or irregular heartbeat; low blood pressure; fatigue; severe nausea, vomiting, or diarrhea; severe headache; or new skin rash. Tell all your healthcare providers that you were treated with TECELRA.

After getting TECELRA, you will be monitored daily at the healthcare facility for at least 7 days after the infusion. You should plan to stay close to a healthcare facility for at least 4 weeks. Do not drive, operate heavy machinery, or do other activities that could be dangerous for at least 4 weeks after you get TECELRA.

Before you receive TECELRA, tell your healthcare provider about all the medicines and supplements you take and your medical conditions, including: seizure, stroke, confusion, or memory loss; heart, liver, or kidney problems; low blood pressure; lung or breathing problems; recent or active infection; past infections that can be reactivated following treatment with TECELRA; low blood counts; pregnancy, you think you may be pregnant, or plan to become pregnant; breastfeeding; or taking a blood thinner.

The most common side effects of TECELRA include nausea, vomiting, fatigue, infection, constipation, fever (100.4°F/38°C or higher), abdominal pain, difficulty breathing, decreased appetite, diarrhea, low blood pressure, back pain, fast heart rate, chest pain, general body swelling, low white blood cells, low red blood cells, and low platelets.

You are encouraged to report side effects to the FDA at (800) FDA‑1088 or www.fda.gov/medwatch or to Adaptimmune at 1‑855‑24MYADAP (855‑246‑9232).

WHAT IS TECELRA?

TECELRA is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you. TECELRA is approved based on patient response data. Additional data are needed to confirm the clinical benefit of TECELRA. It is not known if TECELRA is safe and effective in children.

Please see Medication Guide, including Important Warning.